Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpaWorld, Bringing the NAD-Boosting Benefits of Niagen IV to the High Seas Niagen Bioscience (NASDAQ:NAGE) announced a first-of-its-kind partnership with OneSpaWorld (NASDAQ:OSW) to offer pharmaceutical-grade Niagen IV at more than 80 Medi-Spa clinics aboard high-end cruise ships, expanding Niagen Plus reach to on-vacation consumers.The Niagen IV aqueous formulation is stated to enable 75% shorter infusion times, a faster rise in NAD+ blood levels, a newly granted patent for IV/injectable methods of use, and 500 mg product availability via a U.S. FDA-registered outsourcing facility.

#OSW #NAGE Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpaWorld, Bringing the NAD-Boosting Benefits of Niagen IV to the High Seas

www.stocktitan.net/news/OSW/niagen-bioscien...

Board adds $10M to Niagen buyback after $2.6M repurchased Board lifted the authorization by $10M after about $2.6M in repurchases. Why it matters: the plan can keep reducing shares through Oct. 31, 2027.

#NAGE Niagen Bioscience Increases Share Repurchase Program to $20 Million

www.stocktitan.net/news/NAGE/niagen-bioscie...

Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen®, Contributing to 45 Published Clinical Studies Niagen Bioscience (NASDAQ: NAGE) announced its external research program surpassed 300 material transfer agreements, supporting research at >200 institutions across 34 countries and contributing to 45 published human clinical studies.The program has produced >225 peer-reviewed publications, an estimated $200M+ in third-party research value, and a patent portfolio of 50+ granted patents, reinforcing Niagen's research footprint in NAD+ science.

#NAGE Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen®, Contributing to 45 Published Clinical Studies

www.stocktitan.net/news/NAGE/niagen-bioscie...

Choreute de la chatte

Le Choreute est un insecte aquatique appartenant à la famille des notonectidae, connu pour sa forme distinctive et ses capacités de nage. #Choreute #Insecte #Aquatique #Nage #Notonectidae

Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen® Niagen Bioscience (NASDAQ: NAGE) launched the Niagen Skincare Innovation Lab and debuted Niagen NanoCloud, a limited-release, dermatologist-tested topical powered by patented Niagen (nicotinamide riboside).The waterless, single-use sachet format preserves Niagen until activation; a 30-sachet box is priced at $59 and is available on Tru Niagen’s website. A 6-week consumer study (n=37) reported visible improvements starting in two weeks.

#NAGE Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen®

www.stocktitan.net/news/NAGE/niagen-bioscie...

Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025 Total net sales increased 16% to $33.8 million, with Tru Niagen ® sales of $27.5 million, up 21% from the prior year quarter. Gross margin increased 160 basis points to 64.1%. Net income of $4.1 million compared to $7.2 million in the prior year quarter. Q4 2024 benefited from a $3.5 million reversal of previously accrued royalties and license maintenance fees,...

#NAGE Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025

www.stocktitan.net/news/NAGE/niagen-bioscie...

Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash Transaction Niagen Bioscience (NASDAQ: NAGE) announced the sale of its ChromaDex Reference Standards business to LGC in an all-cash transaction completed on February 24, 2026. The divestiture is intended to streamline operations and allow the company to exit non-core activities to focus on NAD+ science, IP, and commercial growth in the longevity sector.The company says proceeds will be reallocated toward patented Niagen® solutions, clinical and consumer channels, and core R&D and commercialization efforts.

#NAGE Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash Transaction

www.stocktitan.net/news/NAGE/niagen-bioscie...

Pour changer un peu, quelques photos d'un modèle masculin.
#nu #nudeart #blackandwhite #nuexterieur #dos #buste #fesses #nage #eau #water #outdoor #extérieur #shooting

still work in progress, fixed holes in the model, textured it
need to add more to it
:)
(also secondary view if you wanted to see those cheeks :3 )
#unity #snake #snek #nage #furry #scalie

Niagen Bioscience Expands HSA/FSA Access for Tru Niagen®, the Leading NAD+ Supplement in the U.S.* Niagen Bioscience (NASDAQ: NAGE) announced that qualified customers can now purchase Tru Niagen® on www.truniagen.com using HSA/FSA funds via a Truemed Letter of Medical Necessity (LMN) issued by a licensed provider.The partnership with Truemed enables a streamlined checkout for one-time purchases or reimbursement for subscriptions, with approved LMNs valid for 12 months; HSA/FSA eligibility and tax savings vary by account.

#NAGE Niagen Bioscience Expands HSA/FSA Access for Tru Niagen®, the Leading NAD+ Supplement in the U.S.*

www.stocktitan.net/news/NAGE/niagen-bioscie...

Trade Alerts, Monday January 12, 2026 – Crystal Equity Research

Small-cap stocks with declining money flow, Mon Jan 12th - #TLS #STKL #SEPN #RBBN #PRQR #OM #NWL #NAGE #MDWD #IART #HNRG #GEMI #FCCO #EQ #DOMO #CLNN #BTBT #AUTL #SI #OPFI #JBI #CPF #CDRE #AHT - More: crystalequityresearch.com/trade-alerts... - #smallcap

Niagen Bioscience Acquires Existing Core Nicotinamide Riboside (NR) Patent Portfolio from Queen’s University Belfast Niagen Bioscience, Inc., the global authority on NAD+ with a focus on the science of healthy aging, today announced that it has acquired a comprehensive portfolio of existing patents covering nicotinamide riboside and its salt forms from Queen’ s University Belfast, further strengthening the Company’ s long-standing leadership and ownership position in NAD+...

#NAGE Niagen Bioscience Acquires Existing Core Nicotinamide Riboside (NR) Patent Portfolio from Queen’s University Belfast

www.stocktitan.net/news/NAGE/niagen-bioscie...

La nage ! Revenir au corps, sentir l’eau sur la peau, son sourd, légèreté retrouvée. Trop de monde à la piscine, je préfère les grands espaces océaniques, même en hiver, même dans une mer froide. On en ressort tout étourdi, délassé, libéré… c’est la nage.

#illustration #nage #mer #ocean

I’m so tired this morning, I just want to go back to bed, play with my dick and pass out with it still in my hand and wake up to someone playing with it 🥱🥵 #horny #bi #gaymer #tired #touchit #goon #gooner #goonsky #nage #nsfwsky #lewd #lewdsky #dick #cock #softdick #stroking

Brasse De la chatte

La brasse est une nage où le nageur effectue des mouvements simultanés et circulaires des bras et des jambes dans l'eau, permettant un avancement efficace et harmonieux. #nage #mouvement #efficacité #harmonie #brasse

Niagen Bioscience Launches Tru Niagen® Beauty — The First NAD+ Skincare Supplement in the U.S. Featuring Niagen® (Patented Nicotinamide Riboside) Niagen Bioscience, Inc., the global authority on NAD+ with a focus on the science of healthy aging, today announced the launch of Tru Niagen ® Beauty, the first-ever beauty supplement in the US featuring Niagen— the most efficient, effective, and high quality NAD+ booster available. Tru Niagen Beauty expands Niagen Bioscience’ s leadership in NAD+ skincare science...

#NAGE Niagen Bioscience Launches Tru Niagen® Beauty — The First NAD+ Skincare Supplement in the U.S. Featuring Niagen® (Patented Nicotinamide Riboside)

www.stocktitan.net/news/NAGE/niagen-bioscie...

Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID Niagen Bioscience, Inc., the global authority on NAD+ with a focus on the science of healthy aging, today shared promising results from the first-of-its-kind clinical trial published today in The Lancet peer-reviewed journal eClinicalMedicine demonstrating that daily supplementation with Niagen ®, Niagen Bioscience’ s patented nicotinamide riboside...

#NAGE Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID

www.stocktitan.net/news/NAGE/niagen-bioscie...

Niagen Bioscience Announces $10 Million Share Repurchase Program Niagen Bioscience (NASDAQ: NAGE) announced that its Board approved a $10 million share repurchase program to buy back common stock over approximately 24 months. The company may repurchase shares in the open market, through privately negotiated transactions, or by other means, subject to law and market conditions. Timing, method, pricing, and amounts will be determined by management and there is no obligation to repurchase shares. The Program may be modified, suspended, or terminated at any time without prior notice. Management described the Program as a compelling use of company capital. For more information, visit the company website.

#NAGE Niagen Bioscience Announces $10 Million Share Repurchase Program

www.stocktitan.net/news/NAGE/niagen-bioscie...

Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook Niagen Bioscience, Inc. today announced financial results for the third quarter of 2025.. Third Quarter 2025 Financial Highlights Compared to Prior Year Period. Total net sales increased 33% to $34.0 million, with Tru Niagen ® sales of $26.0 million, up 44%. Gross margin increased 100 basis points to 64.5%. Sales and marketing expense as a percentage of net...

#NAGE Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook

www.stocktitan.net/news/NAGE/niagen-bioscie...

Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth Niagen Bioscience, Inc., the global authority on NAD+ with a focus on the science of healthy aging, today announced it has increased its full-year 2025 net sales outlook to 25% to 30% year-over-year growth from 22% to 27%. “Elevating NAD+ is critical for health, especially as we age, and greater attention to this important area of science is valuable for public health...

#NAGE Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth

www.stocktitan.net/news/NAGE/niagen-bioscie...

#Bonnet de #bain néoprène BuddySwim Trilaminate warmth chez #trekexpert 52€ BuddySwim #nage #natation #tritOOshop www.tritooshop.com/id.php?id=37...

Revolutionary NAD+ Booster Niagen IV Shows 20% Higher Levels, Now at 900+ US Clinics Pharmaceutical-grade Niagen IV therapy launches at 50+ iCRYO locations, offering 75% faster infusion than traditional NAD+ IV. Clinical study shows 20% NAD+ level increase in 3 hours.

#NAGE Niagen Bioscience's Pharmaceutical-Grade Niagen™ IV and Injections Now Available at over 50 iCRYO Clinics and More than 900 Total Clinics Nationwide

www.stocktitan.net/news/NAGE/niagen-bioscie...

Republicans who supported DOGE and voted for the #BBB are decimating the VA! Here’s the proof: 2,400 employees fired. Support veterans and the VA. #AFGE #NAGE #NFFE #NNOC/NNU #SIEU

Trump and DOGE undermined the VA’s ability to help veterans.  Republicans brag about what they’re doing for veterans, but here’s what they’ve done: 2,400 VA employees fired, 30,000 jobs eliminated, 400,000 employees had their union contract terminated. #AFGE #NAGE #NFFE #NNOC/NNU #SIEU

Leading NAD+ Research Platform: Niagen Bioscience Launches AboutNAD with Peer-Reviewed Database Niagen Bioscience unveils AboutNAD as comprehensive resource for NAD+ and nicotinamide riboside research, featuring peer-reviewed studies, expert insights, and scientific database.

#NAGE AboutNADⓇ Debuts as the Leading Online Resource for Scientific Advancements in NAD+

www.stocktitan.net/news/NAGE/about-nadr-deb...

Summer vibes

#summer #ete #verano #vibes #swim #swimming #nadar #nadando #nage #nager #croatia #croacia #dubrovnik #sea #mar #mer #water #aqua #agua #eau

VA terminates key union contracts | CNN Politics The Department of Veterans Affairs is terminating collective bargaining agreements with several key government unions representing its employees.

MAGAts doing what they said they would do — kill unions. And aggressively go after labor and collective bargaining. This s&@t move will only hurt Veterans and our health care. Next is privatization. Unions everywhere need to stand up in solidarity. ✊
#AFGE
#SEIU
#NAGE
#NNU
#Union
#ProUnion
#ProLabor

VA terminates union contracts for most bargaining-unit employees - VA News Union contracts for most bargaining-unit employees are terminated by VA.

VA Terminates Union Contracts for Most Bargaining Unit Employees
news.va.gov/press-room/v...
#AFGE #NAGE #NFFE #NNOC #SEIU

Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook Niagen Bioscience (NASDAQ:NAGE) reported strong Q2 2025 financial results, with total net sales increasing 37% to $31.1 million. The company's flagship product Tru Niagen® achieved sales of $22.7 million, growing 22%, while Niagen® ingredient sales surged 135% to $7.4 million. The company reported net income of $3.6 million ($0.05 per share) and improved gross margin by 480 basis points to 65.0%.Key operational highlights include completing patient dosing in the Phase III NOPARK trial for Parkinson's disease, securing an exclusive license agreement with Haukeland University Hospital, and expanding Niagen Plus products to over 800 wellness clinics. The company raised its full-year 2025 revenue growth outlook to 22-27% from the previous 20-25%.

#NAGE Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook

www.stocktitan.net/news/NAGE/niagen-bioscie...